Literature DB >> 3585033

Isolation of Streptococcus milleri from clinical specimens.

A M Kambal.   

Abstract

During a period of 26 months, 80 strains of Streptococcus milleri were isolated from 80 patients with clinical evidence of infection. More than a third of the isolates were from lesions related to the gastro-intestinal tract and a quarter from abscesses of various other sites. The haemolytic activity and group antigenic profile of these isolates are discussed. In addition, the clinical significance of S. milleri isolated from various sites is evaluated.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3585033     DOI： 10.1016/s0163-4453(87)93385-8

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  5 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms.

Authors:  I J Mitchelmore; P G Reilly; A J Hay; S Tabaqchali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

3.  Purification and immunochemical studies of type b carbohydrate antigen of oral Streptococcus milleri.

Authors:  T Yakushiji; M Inoue; T Koga
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  Neonatal infection with Streptococcus milleri.

Authors:  J Raymond; M Bergeret; C Francoual; J Chavinié; D Gendrel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

5.  Microbiological features and pathogenesis of peritonsillar abscesses.

Authors:  I J Mitchelmore; A J Prior; P Q Montgomery; S Tabaqchali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.